Addex Therapeutics Ltd Stock
Stocks
ADXN
CH0029850754
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
11:30:38 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 0.0288 CHF | 0.00% |
|
-30.43% | -48.01% |
| Market Cap | 3.44M 4.28M 3.67M 3.15M 5.93M 408M 5.94M 40.69M 15.91M 206M 16.05M 15.71M 681M | P/E 2024 |
0.8x | P/E 2025 | -0.88x |
|---|---|---|---|---|---|
| Enterprise Value | 1.83M 2.28M 1.96M 1.68M 3.16M 218M 3.17M 21.7M 8.48M 110M 8.56M 8.38M 363M | EV / Sales 2024 |
5.67x | EV / Sales 2025 | 28.1x |
| Free-Float |
43.94% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Addex Therapeutics Ltd
| 1 week | -30.43% | ||
| Current month | -31.43% | ||
| 1 month | -28.36% | ||
| 3 months | -37.39% | ||
| 6 months | -40.00% | ||
| Current year | -48.01% |
| 1 week | 0.03 |  | 0.07 |
| 1 month | 0.03 | | 0.07 |
| Current year | 0.03 | | 0.07 |
| 1 year | 0.03 | | 0.08 |
| 3 years | 0.03 | | 0.26 |
| 5 years | 0.03 | | 1.63 |
| 10 years | 0.03 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tim Dyer
CEO | Chief Executive Officer | 58 | 2013-05-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 40 | 2017-05-31 |
Roger Mills
CTO | Chief Tech/Sci/R&D Officer | 69 | 2016-11-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Lawton
CHM | Chairman | 77 | - |
Tim Dyer
BRD | Director/Board Member | 58 | 2014-12-31 |
Ray Hill
BRD | Director/Board Member | 81 | 2010-05-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/18/26 | Other | Director | 269,561 | 0.1233% | ||
| 3/18/26 | Other | HEAD OF TRANSLATIONAL SCIENCE | 506,765 | 0.2318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -30.43% | -50.34% | -66.04% | 4.27M | |
| +0.10% | +0.44% | +2.80% | +23.74% | 50.96B | |
| +2.34% | +4.04% | +479.10% | +582.86% | 46.18B | |
| -0.73% | +1.16% | +24.42% | +84.78% | 42.73B | |
| +0.79% | +2.88% | +39.53% | +18.77% | 43.04B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 33.48B | |
| -0.47% | +0.44% | +29.96% | +135.17% | 17.28B | |
| -0.38% | -2.21% | - | - | 16.43B | |
| +0.25% | +0.25% | +12.03% | +28.88% | 14.73B | |
| +2.07% | +3.45% | +85.21% | +51.70% | 14.09B | |
| Average | +0.27% | -1.71% | +70.77% | +101.26% | 27.89B | |
| Weighted average by Cap. | +0.38% | +1.16% | +104.32% | +143.89% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 410K 510K 438K 375K 707K 48.73M 709K 4.86M 1.9M 24.56M 1.92M 1.87M 81.28M | 173K 215K 185K 158K 298K 20.54M 299K 2.05M 800K 10.35M 808K 790K 34.27M |
| Net income | 7.06M 8.78M 7.54M 6.46M 12.17M 839M 12.21M 83.55M 32.66M 423M 32.96M 32.25M 1.4B | -6.73M -8.37M -7.19M -6.16M -11.61M -800M -11.64M -79.67M -31.15M -403M -31.43M -30.75M -1.33B |
| Net Debt | -3.3M -4.11M -3.52M -3.02M -5.69M -392M -5.71M -39.07M -15.27M -198M -15.42M -15.08M -654M | -1.6M -2M -1.71M -1.47M -2.77M -191M -2.77M -18.99M -7.42M -96.07M -7.49M -7.33M -318M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | CHF 0.0288 | 0.00% | 1,334,574 |
| 26-08-26 | CHF 0.0288 | +11.63% | 3,666,111 |
| 26-08-25 | CHF 0.0258 | -7.86% | 4,148,380 |
| 26-08-24 | CHF 0.0280 | -20.00% | 4,625,124 |
| 26-08-21 | CHF 0.0350 | -15.46% | 15,284,635 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ADXN Stock
Select your edition
All financial news and data tailored to specific country editions
